Drug Metabolism Letters
Title:Meet Our Editorial Board Member:
Volume: 9 Issue: 2
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
P. Li Albert, Meet Our Editorial Board Member:, Drug Metabolism Letters 2015; 9 (2) . https://dx.doi.org/10.2174/187231280902151027121549
DOI https://dx.doi.org/10.2174/187231280902151027121549 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
23
Related Articles
-
Animal Models For Craniofacial Reconstruction by Stem/Stromal Cells
Current Stem Cell Research & Therapy New Insights into the Roles of Endolysosomal Cathepsins in the Pathogenesis of Alzheimers Disease: Cathepsin Inhibitors as Potential Therapeutics
CNS & Neurological Disorders - Drug Targets Novel Drugs for the Prevention and Treatment of Acute GVHD
Current Pharmaceutical Design Effect of Statin Supplementation on Pulmonary Function and Inflammatory Markers in Patients of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews A QSAR Study on Some Thiophene Derivatives Acting as Anti-HCV Agents
Letters in Drug Design & Discovery Using Cytokines to Treat Cervical Intraepithelial and Invasive Neoplasia
Recent Patents on Anti-Cancer Drug Discovery PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases
Current Pharmaceutical Design Clinical Utility of Biomarkers in Premature Atherosclerosis
Current Medicinal Chemistry A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending a Tertiary Care Hospital
Current Drug Safety Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Current Genomics Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents
Current Topics in Medicinal Chemistry Neuropathic Pain: Is the End of Suffering Starting in the Gene Therapy?
Current Drug Targets State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Current Gene Therapy CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease
Current Drug Targets The Histopathology of Spondyloarthropathy
Current Molecular Medicine A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Current Gene Therapy GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update
Current Vascular Pharmacology Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry